Shu Meng
State Key Laboratory Of Respiratory Disease
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Targeted RNA Therapy Reprograms Fibrotic Macrophages to Reverse Pulmonary Fibrosis.
Journal: Theranostics
Published: January 28, 2026
DOT1L Drives Endothelial-to-Mesenchymal Transition and Fibrotic Vascular Remodeling via H3K79 Methylation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 13, 2025
Hijacking innate immunity to enhance mRNA therapeutics by blocking IFN-P-body-XRN1 axis-mediated degradation.
Journal: Nature communications
Published: August 07, 2025
Innate immune overactivation hinders nuclear reprogramming through IFN-IFNAR1 axis.
Journal: Biochemistry and biophysics reports
Published: May 30, 2025
Super-enhancer-mediated circRNAs exhibit high splicing circularization diversity and transcriptional activity.
Journal: Nucleic acids research
Published: February 10, 2025
Disruption of PRC1 components RING1A and RING1B promotes angiogenesis via relieving BMP4 repression.
Disruption of PRC1 components RING1A and RING1B promotes angiogenesis via relieving BMP4 repression.
Journal: Journal of advanced research
Published: January 05, 2025
Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication.
Journal: Genes & diseases
Published: October 03, 2024
Investigating pulmonary neutrophil responses to inflammation in mice via flow cytometry.
Journal: Journal of leukocyte biology
Published: May 20, 2024
Circular RNAs in vascular diseases.
Journal: Frontiers in cardiovascular medicine
Published: June 27, 2023
Last Updated: 09/26/2026